C3ai Inc
For the period ended Oct 31, 2024. Filed Dec 10, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 31, 2024 · Filed Dec 10, 2024
AI$11.84-1.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
| Three Months Ended October 31, 2024 | ||||||
|---|---|---|---|---|---|---|
| Common Stock · Additional Paid-In Capital · Accumulated Other Comprehensive Income · Accumulated Deficit · Total Stockholders’Equity | ||||||
| Shares · Amount | ||||||
| Balance as of July 31, 2024 | 126,205 | $126 | $2,027,274 | $281 | $(1,152,760) | $874,921 |
| Issuance of Class A common stock upon exercise of stock options, net of repurchases | 634 | — | 1,342 | — | — | 1,342 |
| Vesting of early exercised Class A common stock options | — | — | 110 | — | — | 110 |
| Shares withheld related to net share settlement of equity awards | (118) | — | (2,841) | — | — | (2,841) |
| Vesting of restricted stock units | 1,682 | 2 | 1,250 | — | — | 1,252 |
| Issuance of Class A common stock under employee stock purchase plan | 378 | — | 5,009 | — | — | 5,009 |
| Stock-based compensation expense | — | — | 44,900 | — | — | 44,900 |
| Other comprehensive income | — | — | — | 240 | — | 240 |
| Net loss | — | — | — | — | (65,972) | (65,972) |
| Balance as of October 31, 2024 | 128,781 | $128 | $2,077,044 | $521 | $(1,218,732) | $858,961 |
| Six Months Ended October 31, 2024 | ||||||
|---|---|---|---|---|---|---|
| Common Stock · Additional Paid-In Capital · Accumulated Other Comprehensive Income · Accumulated Deficit · Total Stockholders’Equity | ||||||
| Shares · Amount | ||||||
| Balance as of April 30, 2024 | 123,706 | $123 | $1,963,726 | $(563) | $(1,089,933) | $873,353 |
| Issuance of Class A common stock upon exercise of stock options, net of repurchases | 1,064 | 1 | 4,467 | — | — | 4,468 |
| Vesting of early exercised Class A common stock options | — | — | 216 | — | — | 216 |
| Shares withheld related to net share settlement of equity awards | (225) | — | (5,787) | — | — | (5,787) |
| Vesting of restricted stock units | 3,858 | 4 | 23,528 | — | — | 23,532 |
| Issuance of Class A common stock under employee stock purchase plan | 378 | — | 5,009 | — | — | 5,009 |
| Stock-based compensation expense | — | — | 85,885 | — | — | 85,885 |
| Other comprehensive income | — | — | — | 1,084 | — | 1,084 |
| Net loss | — | — | — | — | (128,799) | (128,799) |
| Balance as of October 31, 2024 | 128,781 | $128 | $2,077,044 | $521 | $(1,218,732) | $858,961 |
| Three Months Ended October, 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · Additional Paid-In Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’Equity | ||||||||
| Shares · Amount | ||||||||
| Balance as of July 31, 2023 | 117,925 | $117 | $1,807,678 | $(758) | $(874,595) | $932,442 | ||
| Issuance of Class A common stock upon exercise of stock options, net of repurchases | 165 | — | 537 | — | — | 537 | ||
| Vesting of early exercised Class A common stock options | — | — | 144 | — | — | 144 | ||
| Shares withheld related to net share settlement of equity awards | (81) | — | (2,647) | — | — | (2,647) | ||
| Vesting of restricted stock units | 1,215 | 1 | — | — | — | 1 | ||
| Issuance of Class A common stock under employee stock purchase plan | 429 | 1 | 5,054 | — | — | 5,055 | ||
| Stock-based compensation expense | — | — | 45,541 | — | — | 45,541 | ||
| Other comprehensive loss | — | — | — | (17) | — | (17) | ||
| Net loss | — | — | — | (69,780) | (69,780) | |||
| Balance as of October 31, 2023 | 119,653 | $119 | $1,856,307 | $(775) | $(944,375) | $911,276 | ||
| Six Months Ended October 31, 2023 | ||||||
|---|---|---|---|---|---|---|
| Common Stock · Additional Paid-In Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’Equity | ||||||
| Shares · Amount | ||||||
| Balance as of April 30, 2023 | 113,943 | $113 | $1,740,174 | $(385) | $(810,237) | $929,665 |
| Issuance of Class A common stock upon exercise of stock options, net of repurchases | 2,251 | 2 | 10,108 | — | — | 10,110 |
| Vesting of early exercised Class A common stock options | — | — | 294 | — | — | 294 |
| Shares withheld related to net share settlement of equity awards | (253) | — | (9,765) | — | — | (9,765) |
| Vesting of restricted stock units | 3,283 | 3 | 21,466 | — | — | 21,469 |
| Issuance of Class A common stock under employee stock purchase plan | 429 | 1 | 5,054 | — | — | 5,055 |
| Stock-based compensation expense | — | — | 88,976 | — | — | 88,976 |
| Other comprehensive loss | — | — | — | (390) | — | (390) |
| Net loss | — | — | — | — | (134,138) | (134,138) |
| Balance as of October 31, 2023 | 119,653 | $119 | $1,856,307 | $(775) | $(944,375) | $911,276 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.